Search - tctmd.com

Displaying 81 - 100 of 109

Sort: Relevancy | Date

Presentation TCT 2013

CHF and Cardiomyopathy

Presenter: Allen Jeremias

October 27, 2013

Presentation Fellows 2013

Septal Ablation for HOCM

Presenter: Srihari Naidu

April 17, 2013

Presentation ECHO 2013

Hypertrophic Cardiomyopathy

Presenter: Mario J. Garcia

April 04, 2013

Presentation TCT 2013

Mid-term Outcomes of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in Patients with Sigmoid versus Neutral Ventricular Septum

Presenter: Josef Veselka, Pavol Tomasov, David Zemanek

January 31, 2013

Presentation TCT 2013

Complications of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy with Focus on Complete Heart Block: A European Multicenter Study

Presenter: Josef Veselka, Thorsten Lawrenz, Christoph Stellbrink, David Zemanek, Marian Branny, Jaroslav Januska, Ladislav Groch, Pawel Dimitrow, Jan Krejci, Maciej Dabrowski, Stanislav Mizera, Horst Kuhn

January 31, 2013

Presentation Cell Therapy 2013

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

Presenter: Leslie Miller

January 24, 2013

News Industry News

Heart Metabolics Receives Funding for U.S. Clinical Development of Heart Failure Drug

January 02, 2013

Presentation TCT 2012

The Future? Radiofrequency Catheter Septal Ablation for HCM

Presenter: Rod Stables

October 25, 2012

Presentation TCT 2012

Long-term Outcomes of Alcohol Septal Ablation

Presenter: Richard Bach

October 25, 2012

Presentation TCT 2012

Inpatient and Outpatient Management After Alcohol Septal Ablation

Presenter: Michael Fifer

October 25, 2012

Presentation TCT 2012

Historical Perspective on Alcohol Septal Ablation

Presenter: Ulrich Sigwart

October 25, 2012

Presentation TCT 2012

HCM Management: What Do the Guidelines Say?

Presenter: Bernard Gersh

October 25, 2012

Presentation TCT 2012

HCM and Sudden Cardiac Death: When to Consider an ICD

Presenter: Bernard Gersh

October 25, 2012

Presentation TCT 2012

Great Case 3

Presenter: Rod Stables

October 25, 2012

Presentation TCT 2012

Great Case 2

Presenter: Carey Kimmelstiel

October 25, 2012

Presentation TCT 2012

Great Case 1

Presenter: Valerian Fernandes

October 25, 2012

Presentation TCT 2012

Epidemiology and Natural History of HCM

Presenter: John Douglas Jr

October 25, 2012

Presentation TCT 2012

Dynamic Obstruction: Mechanisms and Implications for Treatment

Presenter: Carey Kimmelstiel

October 25, 2012

Presentation TCT 2012

Complications: How to Avoid, How to Treat

Presenter: Srihari Naidu

October 25, 2012

Presentation TCT 2012

Case Selection for Alcohol Septal Ablation

Presenter: Sherif Nagueh

October 25, 2012

Advertisement

CHF and Cardiomyopathy

Septal Ablation for HOCM

Hypertrophic Cardiomyopathy

Mid-term Outcomes of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in Patients with Sigmoid versus Neutral Ventricular Septum

Complications of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy with Focus on Complete Heart Block: A European Multicenter Study

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

Heart Metabolics Receives Funding for U.S. Clinical Development of Heart Failure Drug

The Future? Radiofrequency Catheter Septal Ablation for HCM

Long-term Outcomes of Alcohol Septal Ablation

Inpatient and Outpatient Management After Alcohol Septal Ablation

Historical Perspective on Alcohol Septal Ablation

HCM Management: What Do the Guidelines Say?

HCM and Sudden Cardiac Death: When to Consider an ICD

Great Case 3

Great Case 2

Great Case 1

Epidemiology and Natural History of HCM

Dynamic Obstruction: Mechanisms and Implications for Treatment

Complications: How to Avoid, How to Treat

Case Selection for Alcohol Septal Ablation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content